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a  b  s  t  r  a  c  t
Septilin  (Spt)  is a  polyherbal  drug  formulation  from  Himalaya  Drug  Company,  consisting  of extracts  from
different  medicinal  plants  and  minerals.  In  the traditional  system  of medicine,  septilin  is  being used
as  immunomodulatory,  antioxidant  and  anti-inﬂammatory  agent.  In the  present  study,  the  protective
effects  of septilin  against  the  genotoxicity  of  cyclophosphamide  (CP)  a widely  used  alkylating  anticancer
drug  was  evaluated  by  using  in  vivo  micronucleus  (MN)  and  sperm  shape  abnormality  assays  in Swiss
albino  mice.  CP administered  intraperitoneally  at a dose  of 50 mg/kg  b.w.  was  used as positive  mutagen.
Different  doses  of septilin  viz.,  125,  250  and  500  mg/kg  b.w.  was  orally  administered  for 5 consecutive
days.  CP was  administered  intraperitoneally  on  5th day.  MN and  sperm  preparations  were made  after
24  h and  35  days  respectively.  CP  induced  signiﬁcant  MN  in both  bone  marrow  and  peripheral  bloodperm abnormality
ntigenotoxic
cells  and also  a high  frequency  of  abnormal  sperms.  In septilin  supplemented  animals,  no  signiﬁcant
induction  of MN  and  abnormal  sperms  was recorded.  In septilin  supplemented  groups,  a dose dependent
signiﬁcant  decrease  in CP  induced  clastogenicity  was  observed.  Thus  the  current  in  vivo study revealed
the  antigenotoxic  effects  of  septilin  against  CP  induced  damage,  in  both  somatic  and  germ cells  of  Swiss
albino  mice.
©  2016  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Ayurveda, the science of life, derived from spiritual visions were
racticed by Indian Rishis since time immemorial. It still continues
s an important system of medicine and drug therapy, in India.
hroughout the history of civilization, plants have played major
ole in medication for the treatment of various kinds of human dis-
ases. Plants and plant based medicine are the backbone of modern
harmaceutical preparations and they are the major contributors
o the pharmaceutical industry both in India and other countries
102,14]. According to world health organisation more than 80%
f the world population depends on the traditional medicines for
heir primary healthcare units. Plant secondary metabolites are the
rimary active ingredients of ayurvedic drugs. Plants harbour large
Abbreviations: A, amorphous; B, banana shaped; BSA, bovine serum albumin;
MC, carboxymethyl cellulose; CP, cyclophosphamide; DH, double headed; DT,
ouble tailed; F, folded; H, hookless; MN,  micronucleus; MNNCE, micronucleus
n normochromatic erythrocytes; MNPCE, micronucleus in polychromatic erythro-
ytes; NCE, normochromatic erythrocytes; PCE, polychromatic erythrocytes; Spt,
eptilin.
∗ Corresponding author.
E-mail addresses: shruthisujnan@gmail.com (S. Shruthi), kkv36@yahoo.co.in
K.K. Vijayalaxmi).
ttp://dx.doi.org/10.1016/j.toxrep.2016.07.001
214-7500/© 2016 Published by Elsevier Ireland Ltd. This is an open access article under license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
number of active ingredients in valuable in controlling the diverse
group of diseases. Several prescription drugs in the developed
countries contain plant components and more than 100 important
prescription drugs are derived from plants [49]. The medicinal val-
ues of plants are due to some speciﬁc chemical substances which
produce deﬁnite physiological action on the human body [14]. A
single plant may  contain number of bioactive compounds which
may  act singly or synergistically to impart beneﬁcial health effects.
At global level, there is an increased demand for the pharmaceu-
tical products of plant origin or other natural sources, because of
the fact that the allopathic drugs have unwanted side effects which
may be hindrance for their therapeutic use. Further, plant based
therapy are marked due to its low cost, easy availability [58].
In recent years much attention is being given for the discovery
of cell/genoprotective agents from the natural sources against the
damaging effects of chemicals and radiations. Numerous studies
have been carried out in the last four decades to identify the com-
pounds that might protect the humans against the DNA damage
and its consequences. In this line, more emphasis has been given
to the medicinal plants and their isolated bioactive components.
Septilin, is one of the ayurvedic herbo mineral [46] preparation
of the Himalayan Drug Company containing extracts of six dif-
ferent plants and powders of Blasmodendron mukul and shankha
bhasma. There are reports on the antibacterial, antiinﬂammatory,
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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mmunomodulatory and immunopotentiating effects of septilin
nd it is extensively used for the treatment of several acute and
hronic infections [62,45].
Among the currently available test systems to evaluate the
enotoxicity/clastogenicity of the various test agents, micronucleus
ssay is the most widely applied methods due to its simplicity, relia-
ility, sensitivity and proven suitability for genotoxicity evaluation
27,15].
Micronuclei (MN) are chromatin containing bodies, appearing
s small satellite nucleus in the cell arising from acentric chro-
osomal fragments or from entire chromosome that is lagging at
naphase [56,89,81]. Presence of micronuclei in cells is an indi-
ator of damage to the DNA. The in vivo micronucleus tests using
aematopoietic bone marrow and peripheral blood cells are widely
sed methods for the assessment of genotoxicity of chemicals in
xposed organisms. The rodent bone marrow micronucleus assay is
he measure of both clastogenicity/aneugenicity of target chemical
59]. It has helped a lot to understand the dose response relation-
hip for aneugens and clastogens [23]. Micronucleus is a biomarker,
hich is used widely in biomonitoring studies to determine the
enetic risk due to the exposure to environmental chemicals [10].
resence of micronuclei in the peripheral blood is found to be as
n important biomarker, which shows the risk of cancer develop-
ent [11,25]. Hernandez et al. [36] investigated the applicability of
N data to derive cancer potency information. They explored rela-
ionship between dose response data from genotoxicity tests and
arcinogenicity studies and they observed a positive correlation
etween these two.
The number of mature (normochromatic) erythrocytes in the
eripheral blood that contain micronuclei among a given num-
er of mature erythrocytes can also be used as the end point of
he assay when animals are continuously treated with the test
gents [65]. Micronucleus assay is also being used as biologi-
al dosimeter of in vivo ionising radiation exposure [107]. There
re many reports of clastogenecity and anticlastogenecity studies
here bone marrow micronucleus assay was used as one of the
arameters [57,95,67,73,74,63]. Several workers used peripheral
lood micronucleus assay method to evaluate the clastogenic and
nticlastogenic potency of different agents [21,50,64].
In animals, exposure of the males to toxic chemicals and radi-
tion can result in wide variety and combination of reproductive
ysfunction such as changes in the sexual behaviour, spermato-
enic killing, diminished sperm quantity and quality, chromosomal
efects in germ cells, reduced fertility etc.  [108]. Epidemiological
tudies have shown cytotoxic and genotoxic effects of chemother-
peutic drugs and impaired fertility in males [7]. The mouse sperm
orphology test is commonly used for measurement of spermato-
enic damage induced by test agents. Studies have shown that
nduced changes in sperm morphology reﬂect the genetic dam-
ge in male germ cells. Sperm assays are commonly used to detect
he causes of infertility. Here, mainly sperm counts, motility of
perms, and sperm morphology are being used as test parameters
93]. There are several reports on chemically induced abnormal
perms. [75] reported the sperm abnormalities in mouse germ
ells after short term exposure to pesticides acetamiprid, propineb
nd their mixture. From various studies it has been concluded
hat chemicals yielding positive response in mouse sperm mor-
hology test should be regarded as suspected germ cell mutagens
n mammals and agent’s positive responses in these sperm tests
hould be considered with high priority against human applica-
ions [110,111]. Sperm abnormality assay is extensively being used
or the evaluation of genotoxicity of chemicals and also for the
tudy of antigenotoxic protective effects of natural compounds
40,9,26,73,74,4,12,24,91]. In addition, sperm abnormality assay is
lso being used to study the endocrine mediated effects to assess
he potency of endocrine disrupting chemicals on hormone homeo-gy Reports 3 (2016) 563–571
stasis and also studies indicated the risk of lowered fertility due to
decreased spermatogenesis in such exposed animals [114].
Cyclophosphamide (CP) is widely used anticancer and
chemotherapeutic drug [90]. However, despite its wide spec-
trum of clinical beneﬁts it can also induce cytotoxic effects on the
normal cells in humans and experimental animals [44]. CP is an
alkylating agent capable of inducing gene mutations, chromosomal
aberrations, micronucleus (MN), sister chromatid exchanges, as
well as other genotoxic effects [51,1]. Since CP is a well-known
mutagen/genotoxin, in the present study it was  used as a positive
mutagen. There are several reports on the use of CP to evalu-
ate the anticlastogenic/antigenotoxic effects of various natural
compounds and other chemicals [87,61,28,92,32,33,18,70]. [42]
reported the anticlastogenic effect of Ricinus communis extract
against CP induced clastogenicity in mice bone marrow cells.
Since there are very few reports on the chemoprotective effects
of septilin, the present study was undertaken to investigate its in
vivo anticlastogenic effects against CP induced clastogenicity by
using micronucleus assays in bone marrow and peripheral blood
cells and sperm abnormality assay in germinal cells. Both test sys-
tems used in present study have the same sensitivity, speciﬁcity and
accuracy and are being used as short term tests for the evaluation
of carcinogenecity. Whereas, sperm morphology assay is useful in
screening test for compounds that constitutes a potential genetic
hazard for mammals.
2. Materials and methods
2.1. Chemicals
Septilin (The Himalayan drug company, Peenya Industrial
Area, Bangalore, Batch No.-37300170B), containing the extracts of
Maharasanadi qoath (130 mg), Tinospora cordifolia (98 mg), Rubia
cordifolia (64 mg), Emblica ofﬁcinalis (32 mg), Moringa pterigosperma
(32 mg), Glycyrriza glabra (12 mg)  and powders of Balsamodendron
mukul (324 mg), Shankha bhasma (64 mg)  was  used.
Cyclophosphamide (CP-CAS No.-6055-19-2), Endoxan- N Bax-
ter Oncology, Germany, Batch No.-JN1045 was  used as the positive
control. All other chemicals were obtained either from Merck, SRL
and Hi-media, India.
2.2. Animals
Swiss albino mice belonging to Mus  musculus species, bred and
maintained in the institutional animal house were used for the
experiment. They were housed in polypropylene shoe box type
cages, bedded with rice husk and kept in air-conditioned room, at
23◦ C (±2◦ C) and RH 50 ± 5%, were fed with a pelleted diet (Amruth
Feeds, India) and water ad libitum. 8–10 weeks old animals with
average body weight of 25 ± 2 gms  were used for the experiments.
Five animals (3 females + 2 males) were used for each treatment and
control group in micronucleus assays. In sperm abnormality assay,
8 week old male animals were used. All groups of animals were
kept under an absolute hygienic condition as per the recommended
procedures by fulﬁlling the necessary ethical standards. Care and
experimental procedures were conducted as per the guidelines
of CPCSEA, India. In vivo animal studies were conducted after
obtaining the prior approval from Institutional Animal Ethics Com-
mittee (IAEC) of Mangalore University (MU/AZ/99/2013-14/IAEC
dt: 2.04.2013).
2.3. Dose and treatment scheduleScheme of an appropriate dosing schedule and regimen should
be based on clinical use, exposure pattern, pharmacokinetics and
practical consideration. If the substance is genotoxic highest dose
oxicology Reports 3 (2016) 563–571 565
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evel used will show the evidence of adverse effects and maximum
olerated dose is normally used to set this dose level. Accord-
ngly, doses of septilin selected for this study were 125, 250 and
00 mg/kg b.w. The LD50 value of septilin has been reported as
250 mg/kg b.w. in mice [38]. Different doses of septilin prepared
n 0.5% carboxymethyl cellulose (CMC) were orally administered
o different groups of animals in 0.2 ml  quantity for 5 days at 24 h
nterval. CP the positive control agent (50 mg/kg b.w.) dissolved in
terile distilled water was administered intraperitoneally in 0.1 ml
uantity on the 5th day, one hour after the last treatment of septilin.
fter 24 h, peripheral blood was drawn from the tail vein from all
ifferent groups of animals and then they were euthanized by cervi-
al dislocation; bone marrow cells were extracted and processed for
icronucleus assay. Sperm abnormality assay, was done after 35th
ay of last treatment. 0.5% CMC  and distilled water administered
roups were maintained separately which formed the negative
ontrols.
.4. Bone marrow MN  assay
Bone marrow MN  preparations were made by employing the
odiﬁed method of Schmid [81,83] and by following the stan-
ard guidelines of OECD [65]. Here, 5% bovine serum albumin (BSA)
repared in phosphate buffered saline (PBS; pH-7.2) was  used as
uspending medium. The bone marrow suspension was centrifuged
t 1000 rpm and pellet was resuspended in required quantity of
SA mixed thoroughly and drop of suspension was smeared on
lean slides and air dried. The dried slides were ﬁxed in methanol
nd stained with buffered (pH 6.8) May-Grunwald-Giemsa. 2000
olychromatic erythrocytes (PCE) and normochromatic erythro-
ytes (NCE) in the corresponding ﬁeld were screened from each
nimal to score the MN  and to determine P/N ratio.
.5. Peripheral blood MN  assay
The peripheral blood MN  assay was done by using the method
f Schlegel and MacGregor [82] by applying the standard guide-
ines of OECD [65]. The peripheral blood drawn from the tail vein
ere smeared on clean slides, dried and ﬁxed in absolute methanol.
he slides were stained with buffered Wright’s-Giemsa (pH-6.8).
bout 2000 NCE per animal were scanned for the presence of MN
nd number of PCE present in the corresponding focus were scored
rom each animal to determine the effects of test agents on the
rythropoiesis.
.6. Sperm abnormality assay
The sperm abnormality assay was done according to the method
f Wyrobek and Bruce [109] and Vega et al. [104] by following stan-
ard OECD guidelines OECD [66]. The doses of septilin and CP and
reatment schedule were same as that of micronucleus tests. One
ost treatment sampling time i.e.,  35 days was used for this study.
his is based on the principle that, the germ cells which are exposed
t a late spermatogonial stage to the chemical, would reach the
auda epididymis after undergoing a series of changes during the
ourse of development to give rise to sperms which are analysed for
hape abnormalities and variations in the sperm count. Initial body
eight of the animals was taken before the start of the experiments
nd ﬁnal body weight was taken on 35th day just before euthaniz-
ng the animals. Animals were euthanized by cervical dislocation
nd the testes were dissected out and weighed. Both the cauda
pididymis were removed and placed in a watch glass contain-
ng 1 ml  phosphate buffered saline (pH = 7.2). The cauda epididymis
as minced thoroughly and the suspension obtained was ﬁltered
hrough a ﬁne mesh cloth to remove tissue debris and stained with
% aqueous eosin for about 20 min. A drop of the sperm suspensionFig. 1. Effect of septilin on MN PCE and Total MN induced by CP. ANOVA test,
*p < 0.05, **p < 0.01, *** p < 0.001.
was smeared on a clean slide [105]. Sample is collected concur-
rently from all 5 animals, from each group. Two thousand sperms
per animal were scored from each group for the presence of sperm
shape abnormalities following the criteria of Wyrobek and Bruce
[109]. For sperm count, an aliquot (0.05 ml)  from the sperm sus-
pension (1 ml)  was  diluted (1:40) with PBS and mixed thoroughly.
Diluted sperm suspension was introduced into the Neubaur count-
ing chamber and the total sperm count in 8 squares of 1 mm2 was
determined and multiplied by 5 × 104 to calculate the number of
sperms per epididymis.
2.7. Statistical analysis
Statistical signiﬁcance of the results was tested by comparing
treatment groups with the respective control group by employ-
ing one way  ANOVA and Dunnett’s post hoc tests using Graph pad
prism 5 (GraphPad Software, Inc., CA, USA). Differences with a P-
value of 0.05 or lower were considered to be statistically signiﬁcant.
3. Results
CP induced statistically signiﬁcant MN  in both bone marrow
and peripheral blood cells (Tables 1 and 2). Septilin alone did not
induce signiﬁcant MN  at any of the doses tested compared to CMC
control. In the combined treatment group, septilin induced signif-
icant reduction in the MN frequencies in bone marrow cells at all
doses tested (Fig. 1). In peripheral blood cells also in the CP + septilin
treated groups, a signiﬁcant reduction in MN in NCE (Fig. 3) and an
increase in the mean percent PCE were observed (Fig. 5). Present
study revealed the anticlastogenic potency of septilin against anti-
cancer drug CP. All the three doses of septilin showed positive
response as a protective agent against CP. Among these three doses
250 mg/kg b.w. dose was found to be more effective than other two
doses (Figs. 2 and 4).
In sperm abnormality assay CP induced signiﬁcant frequency of
abnormal sperms. Different types of abnormal sperms like amor-
phous, hookless, folded, banana, double headed and double tailed
were observed (Table 3). Signiﬁcant reduction in body weight, rel-
ative testes weight and sperm count were also observed (Table 4).
Septilin alone did not induce any signiﬁcant effects on all the
above mentioned parameters. In the combined treatment groups,
different doses of septilin signiﬁcantly reduced the frequency of
abnormal sperms induced by CP. Furthermore, septilin has shown
its protective effect on germ cells by increasing the body weight,
relative weight of testes, as well as sperm count signiﬁcantly (Fig. 6).
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Table 1
Frequency of micronucleus and total MN in bone marrow cells of animals treated with different doses of septilin and CP and their respective controls at 24 h time interval.
Treatment mg/kg MNPCE ± SEM (%) % inhibition Total MN ± SEM (%) % inhibition P/N ± SEM
Dist. Water 0.09 ± 0.02 – 0.05 ± 0.02 – 1.10 ± 0.02
CMC  0.5% 0.10± 0.01 – 0.06 ± 0.01 – 1.10 ± 0.02
Spt  125 0.04 ± 0.02 – 0.02 ± 0.02 – 1.16 ± 0.02
Spt  250 0.01 ± 0.01 – 0.01 ± 0.01 – 1.30 ± 0.02
Spt  500 0.01 ± 0.01 – 0.01 ± 0.01 – 1.22 ± 0.02
CP50  2.20 ± 0.02c – 1.66 ± 0.02c – 0.58 ± 0.01c
CMC+ CP50 2.12 ± 0.05 3.64 ± 0.02 1.59 ± 0.02 4.22 ±0.01 0.59 ± 0.00
Spt  125+ CP50 1.18 ± 0.05c 46.4 ± 0.02c 0.79 ± 0.06c 52.4 ±0.02c 0.85 ± 0.01c
Spt 250 + CP 50 0.32 ± 0.05c 85.5 ±0.01c 0.17 ± 0.02c 89.8 ±0.01c 0.91 ± 0.02c
Spt 500 + CP 50 0.70 ± 0.07c 68.2 ±0.03c 0.37 ± 0.01c 77.7 ±0.03c 0.87 ± 0.02c
ANOVA test, ap < 0.05, b p < 0.01, cp < 0.001.
Table 2
Results of peripheral blood MN  test in animals treated with different doses of septilin and CP and their respective controls at 24 h time interval.
Treatment mg/kg Mean%NCE Mean% PCE Mean% of MN in NCE ± SEM % Inhibition
Dist. Water 98.1 ± 0.10 1.90 ± 0.09 0.05 ± 0.05 –
CMC  0.5% 98.0 ± 0.07 2.00 ± 0.09 0.03 ± 0.01 –
Spt  125 97.6 ± 0.06 2.40 ± 0.03 0.02 ± 0.01 –
Spt  250 97.8 ± 0.01 2.20 ± 0.09 0.02 ± 0.01 –
Spt  500 97.8 ± 0.10 2.20 ± 0.01 0.02 ± 0.01 –
CP50  98.9 ± 0.02 1.10 ± 0.03c 0.53 ± 0.03c –
CMC+  CP50 98.8 ± 0.02 1.20 ± 0.03 0.49 ± 0.02 7.50 ± 0.03
Spt  125 + CP50 98.8 ± 0.02 1.30 ± 0.04a 0.28 ± 0.03c 47.2 ± 0.03c
Spt 250 + CP50 98.3 ± 0.09 1.70 ± 0.10c 0.09 ± 0.02c 83.0 ± 0.04a
Spt 500 + CP50 98.7 ± 0.04 1.50 ± 0.03b 0.18 ± 0.03c 66.0 ± 0.06c
ANOVA test: ap<0.05, bp < 0.01, cp < 0.001.
Table 3
Different types and total abnormal sperms induced by CP (50 mg/kg b.w.) and the ameliorating effect of septilin (5 weeks post treatment period).
Treatment* mg/kg A H F B DH DT Total % Abnormal sperms ± SEM
Dist. Water 76 44 2 0. 0 0 122 1.22 ± 0.05
CMC  0.5% 76 43 2 0 0 0 121 1.21 ± 0.05
Spt  125 55 48 0 0 0 0 103 1.03 ± 0.04
Spt  250 28 15 0 0 0 0 43 0.43 ± 0.03
Spt  500 41 17 0 0 0 0 58 0.58 ± 0.03
CP50  250 136 88 38 28 23 563 5.63 ± 0.24
CMC+  CP50 247 135 87 36 25 20 550 5.50 ± 0.22
Spt  125 + CP50 189 130 71 30 07 08 435 4.35 ± 0.03c
Spt 250 + CP 50 76 46 53 16 04 04 199 1.99 ± 0.20c
Spt 500 + CP 50 87 58 50 25 07 05 232 2.32 ± 0.03c
A—Amorphous; H—hookless; F—folded; B—Banana shaped; DH—Double Headed; DT—Double Tailed.
* Five animals in each group; 2000 sperms/animal; ANOVA test, ap < 0.05, bp < 0.01, cp < 0.001.
Table 4
Effect of different doses of septilin and controls on body weight, testes weight and sperm count in mice.
Treatment* mg/kg Initial b.w(gms) Final b.w(gms) Testes wt. (gms) ± SEM Relative wt. of testes ± SEM Sperm count/epididymis (×106) ± SEM
Dist. Water 27.91 32.88 0.31 ± 0.01 0.94 ± 0.01 7.95 ± 0.15
CMC  0.5% 27.33 32.13 0.32 ± 0.02 0.99 ± 0.01 7.75 ± 0.42
Spt  125 26.14 31.60 0.32 ± 0.02 1.01 ± 0.01 8.00 ± 0.23
Spt  250 26.94 32.08 0.33 ± 0.04 1.03 ± 0.02 8.63 ± 0.23
Spt  500 26.78 31.22 0.32 ± 0.02 1.02 ± 0.01 8.13 ± 0.40
CP50  25.46 29.58 0.24 ± 0.01 0.81 ± 0.03 5.25 ± 0.38
CMC+  CP50 26.66 30.94 0.24 ± 0.01 0.78 ± 0.03 5.38 ± 0.40
Spt  125+ CP50 23.78 28.48 0.25 ± 0.02a 0.88 ± 0.06a 6.75 ± 0.23c
Spt 250 + CP 50 25.44 30.12 0.33 ± 0.01a 1.10 ± 0.03a 8.00 ± 0.23c
4
g
t
p
a
eSpt 500 + CP 50 27.68 31.80 0.32 ± 0.01a
* Five animals in each group, ANOVA test, ap < 0.05, b p < 0.01, c p < 0.001.
. Discussion
CP is a well known cytotoxic genotoxin. One of the useful strate-
ies for the protection against chromosomal damage induced by
his type of agents is using the compounds which are capable of
reventing the future damages or repairing an already made dam-
ge [18]. In the present investigation, septilin was used to study its
ffect on the cytogenetic damage induced by CP.1.00 ± 0.03a 7.70 ± 0.15c
Septilin is an ayurvedic herbomineral formulation which has
a number of beneﬁcial health effects. It consists of six different
medicinal plant extracts. These plants in their individual capacities
also have medicinal properties. In view of this, septilin was selected
to study its protective effects against CP induced genotoxicity. In the
present study, it demonstrated effective chemoprotective proper-
ties against the CP induced clastogenecity in in vivo mouse and
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Fig. 2. % inhibition of CP induced MN  by septilin. ANOVA test, *p < 0.05, **p < 0.01,
***p < 0.001.
Fig. 3. Effect of septilin on MN NCE induced by CP. ANOVA test, *p < 0.05, **p < 0.01,
*** p < 0.001.
Fig. 4. % inhibition of MN NCE in peripheral blood by septilin in combined treatment.
ANOVA test, *p < 0.05, **p < 0.01, *** p < 0.001.
Fig. 5. Effect of septilin on% of PCE in peripheral blood with CP alone and with
combination of septilin. ANOVA test, *p < 0.05, **p < 0.01, *** p < 0.001.Fig. 6. Effect of septilin on sperm count with CP alone and with combination of
septilin. ANOVA test, *p < 0.05, **p < 0.01, *** p < 0.001.
it did not induce any cytotoxic effects. The results revealed the
anticlastogenic and genoprotective effects of septilin.
There are some reports on the beneﬁcial cellular effects of sep-
tilin. Kumar et al. [47] reported the chemoprotective action of
septilin against CP induced toxicity in mouse. Septilin improved
the total WBC  count, haemoglobin levels and bone marrow cel-
lularity in the CP treated animals. In another study, they showed
the immunopotentiating effects of septilin [46]. It augmented the
cellular immune responses and activated the humoral responses
[48].
Ameliorative effect of septilin has been proved against gamma-
irradiation induced oxidative stress and tissue injury in rats. In
this study septilin administration for ﬁve consecutive days prior to
gamma  irradiation restored the depleted levels of cellular antioxi-
dants and lowered the radiation induced lipid peroxidation [55].
Septilin has been reported as an antioxidant against radiation
induced sickness and mortality and also increased the GSH level
and reduced the lipid peroxidation. Septilin also showed anti-
inﬂammatory and analgesic effects [45].
In the present study solvent controls dist. water, 0.5% CMC  and
septilin alone groups did not induce any signiﬁcant effects on dif-
ferent parameters used. In turn, different doses of septilin induced
protective effects against the CP induced genotoxic effects.
There are many reports on the protective effects of individual
plants present in the septilin. Parvaiz et al. [68], Roshan et al. [76]
and Saxena [80] reviewed the medicinal properties of Glycyrrhiza
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labra including anticancer and antioxidant effects. There are
everal review articles on the pharmacological properties of Gly-
yrrhiza glabra and its bioactive compounds [16,2,5,30,43,102,34].
Tripathi et al. [101], Damle [16] and Devprakash et al.
19] reviewed the phytochemical and pharmacological proﬁle of
inospora cordifolia (TCE). Sharma et al. [88] reported the radiation
nduced testicular injury and its amelioration by Tinospora cordi-
olia extract. Pretreatment with TCE protected the testicular cells
rom radiation damage. The effect is attributed to various factors
specially efﬁcient free radical scavenging. In the present study,
eptilin showed the protective effects against CP induced chromo-
omal damage. Probably the mechanism of action may  be similar
o the radiation protection events. Tinospora cordifolia also showed
rotective action against radiation induced biochemical alterations
n liver. Irradiation of mice resulted in the elevation of biochem-
cal parameters whereas; pretreatment with Tinospora cordifolia
estored such alteration compared with radiation alone treated
roup [85]. Pretreatment with the extract of Tinospora cordifolia
meliorated the irradiation induced histopathological changes in
ice ovarian tissue showing its protective effect against gamma
adiation induced tissue damage [84].
Deoda et al. [20], evaluated the pharmacognostic, phytochem-
cal and pharmacological properties of Rubia cordifolia, another
lant component of septilin. Priya and Siril [71], also studied the
harmacognostical and phytochemical characters of Rubia cordifo-
ia and further they reviewed the different medicinal properties of
ubia cordifolia in the treatment of various ailments. [41], suggested
hat Rubia cordifolia can be used as an adjuvant with chemother-
peutic drugs since, in their study it showed the reduction in
he renal damage induced by chemotherapeutic drug cisplatin. As
tated by them, antioxidant and free radical scavenging proper-
ies of Rubia cordifolia may  be exerted a protective effect against
isplatin induced nephrotoxic effects. Tripathi and Singh [100]
bserved the protective effects of alcoholic root extract of Rubia
ordifolia against radiation induced lipid peroxidation, hemopoi-
tic injury and genotoxicity. Tripathi and Singh [100] observed the
adioprotective effects of alcoholic root extract of Rubia cordifolia.
n this study, he showed the increased rate of animal survival and
ecreased level lipid peroxidation and also micronuclei in extract
upplemented groups there by protecting against radiation induced
ipid peroxidation, hemopoietic injury and genotoxicity. [52] eval-
ated the in vivo antioxidant effects of alcoholic extracts of Rubia
ordifolia against lead nitrate induced free radical mediated tox-
city simultaneously by increasing the activity of SOD, CAT, and
SH in liver and testis of mice and also by decreasing the lipid
eroxidation.
There are several reports in the genoprotective effects of Emblica
fﬁcinalis. In vivo protective effect of Emblica ofﬁcinalis extract
gainst the genotoxicity of benzo[a]pyrene and CP was  studied
y using bone marrow chromosomal aberration and micronu-
leus assays in mice [86]. Banu et al. [8] noticed the protective
ffect of ethanolic extract of Emblica ofﬁcinalis fruit extract in
wiss albino mice thereby reducing the frequency of bone marrow
icronuclei and increased the liver antioxidants induced by 7,12-
imethylbenz(a)anthracene (DMBA) a rodent carcinogen which
nturn showed its antigenotoxic effect. Dasaroju and Gottumukkala
17] reviewed the pharmacological proﬁle of Emblica ofﬁcinalis.
hakraborty and Verma [13] evaluated the ameliorative effect of
queous extract of Emblica ofﬁcinalis against ochratoxin induced
permatotoxic effects in mice. Protective effect of Emblica ofﬁci-
alis is further encouraged by Chakraborty and Verma [13]. In their
tudy, plant extract alleviated the ochratoxin-induced reproductive
lterations such as decreased sperm count, motility and viabilty in
ice. This possible effect is mainly due to the free radical scaveng-
ng property of this plant.gy Reports 3 (2016) 563–571
Sathya et al. [79] demonstrated that phytoconstituents present
in the of Moringa oleifera Lam./Moringa pterygosperma leaves ren-
dered protection against cyclophosphamide induced micronucleus
and DNA damage in the bone marrow and liver tissue of mice.
Tejas et al. [97] and Anwar et al. [6] reviewed the pharmacognostic,
pharmacological, nutritional and therapeutic properties of Moringa
pterygosperma. Also, Luqman et al. [54], studied the antistress,
antioxidant, and scavenging potential of Moringa pterygosperma by
using in vitro and in vivo assays. As a result, the ethanolic fruit
extract showed strong free radical scavenging capacity in both
in vitro and in vivo conditions.
Rout et al. [78] reviewed the medicinal and therapeutic proper-
ties of Blasmodendron mukul (guggul). Xiao and Xiao [112] reported
the potent chemopreventive and chemotherapeutic properties of
guggul on human prostate cancer cell lines.
In Indian traditional system of medicine, Shankha bhasma is
used for therapeutic purposes. It is a powder prepared by incinerat-
ing the conch shell containing different calcium salts [31,96]. Also,
Vardini et al. [103] proved the nongenotoxic properties of bhas-
mas  by using in vivo bone marrow micronucleus assay and alkaline
comet assay to assess clastogenic and aneugenic effects and also to
detect the intensity of DNA damage in Wistar rats.
CP is a well-known anticancer, chemotherapeutic and immuno-
suppressive drug, which was used as a clastogenic agent in the
present study. The results obtained in this study revealed the pro-
tective effects of the septilin against the genotoxicity of CP in
mouse. Administration of CP alone induced signiﬁcant micronuclei
in both bone marrow and peripheral blood cells and also it reduced
the P/N ratio in bone marrow cells. Although CP has potent ther-
apeutic value it also shows wide spectrum of cytotoxicity against
normal cells which is a hindrance for its usage. The cytotoxicity of
drug is mainly due to its ability to damage DNA. CP is an alkylating
agent and its alkyl group can bond with nucleic acids resulting in
DNA strand breaks, micronuclei formation and ultimately by the
cell death [37]. CP showed signiﬁcant effects in all the parame-
ters used. In the combined treatment groups, septilin signiﬁcantly
reduced MN induced by CP and it enhanced the P/N ratio signif-
icantly. In the peripheral blood also CP signiﬁcantly reduced the
mean percent of PCE, and also it reduced the frequency of MN in
NCE induced by CP.
The sperm morphology assay, is one of the most widely used
genetic toxicology assays, has potential in identifying chemi-
cals that induce spermatogenic dysfunction and perhaps heritable
mutations Wyrobek [107]. Furthermore, the development of sperm
head abnormality has been used as a reliable short-term biolog-
ical indicator in the evaluation of chemical genotoxicity [53,29].
In the present ﬁndings, signiﬁcant increase in the percentage of
sperm head abnormalities, reduced relative testes weight and
sperm count were observed in the CP treated group. Pretreatment
of animals with septilin signiﬁcantly decreased the percentage of
abnormal sperms and there was an increase in the sperm count and
relative testes weight, which demonstrate the protective effect of
septilin on germinal cells.
Although it is difﬁcult to elucidate the exact mechanism of
antigenotoxic effect of septilin, it could be possible to explain
the reasons for these effects based on some of the related stud-
ies conducted by different investigators. Vilar et al. [106] studied
the antimutagenecity protection of Ginkgo biloba extract against
mitomycin C and CP in mouse bone marrow. According to them
there are some common mechanism of action of plant extracts such
as antioxidant activity, free radical scavenging and even the gene
regulation which contributes its direct or indirect anti mutagenic
effects. CP is an alkylating anticancer drug which is activated in
vivo by passing through various metabolic steps producing reac-
tive molecules. Scavenging of these reactive molecules is one of the
important techniques in the armoury of antimutagenesis. This may
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e one reason for the protective effect of septilin. Similar hypothesis
as been given by Hosseinimehr and Karami [37] while reporting
he chemoprotective effects of captopril against CP induced geno-
oxicity. They reported the reduction of CP induced genotoxicity
n bone marrow cells and they opine that this effect is due to the
ntioxidant activity of thiols in captopril. In our own  study, we
bserved the antioxidant effects of septilin against CP, as revealed
y signiﬁcant enhancement of liver SOD and GSH in the combined
reatment group (to be published elsewhere). Alija et al. [3] studied
he cytotoxic and genotoxic effects of - carotene and its cleav-
ge products (CP) in rat hepatocytes. They opine that the genotoxic
ffects may  be due to the prooxidant properties of CP or direct or
ndirect action on DNA. Delarmelina reported the antimutagenic
ctivity of ipriﬂavone against DNA damage induced by CP in mice.
robable mechanisms proposed by them are desmutagenesis or
io antimutagenesis. Although in the present study it is difﬁcult
o elucidate the mechanisms, septilin is containing extracts of var-
ous plants which possess ﬂavonoids thereby eliciting protective
ffects. There are several reports on such effects of plant extracts,
ioactive constituents and natural compounds. Flavonoids are the
henolic compounds which are naturally found in fruits, vegeta-
les and other plant parts. They have many favourable biological
ffects due to their antioxidant and free radical scavenging abili-
ies. However, at higher doses they act as prooxidants. Prooxidants
how cytotoxic and clastogenic properties [113]. Tourino et al. [99]
eported the antioxidant/prooxidant effects of bioactive polyphe-
olics. According to them the most effective antioxidants are also
he most cytotoxic and effective anti-proliferative agents, may
e due to the dual antioxidant/prooxidant effect of polyphenols.
lthough, various doses of septilin showed signiﬁcant genoprotec-
ive effect against CP, maximum effect was observed at middle dose
250 mg/kg b.w.) and there was no increased effect at highest dose.
here are several reports on the phytocomponents of individual
lants extract present in septilin, which are known biological pro-
ective agents. Sharma and Agrawal [87] studied the antigenotoxic
ffects of Glycyrrhiza glabra root extract against CP induced chro-
osomal aberration in Swiss albino mice. According to them the
rotective effect is due to the reduced immunosuppressant effects
f CP by Glycyrrhiza glabra and presence of the phytotherapeutic
olecules such as ﬂavonoids, tannins, saponins, triterpinoids in
his plant. Parvaiz et al. [68] also reported the presence of these
ompounds in a review on this plant. Pendli et al. [69] carried out
hytochemical analysis of extracts of various plant parts of Rubia
ordifolia Promkum et al. [72] studied anticlastogenic effects of
oringa oleifera against mitimycin C (MMC)  and 7, 12-dimethyl
enz(a)anthracene, potent clastogens. They are of the view that
he protective effect of this plant due to the presence of various
utrients and phytochemical compounds such as -carotene, vita-
ins and various phenolics. Torres-Castillo et al. [98] reported the
resence of polyphenols, alkaloids and saponins in Moringa oleifera.
Our study revealed the protective effects of septilin against CP
nduced damage in both somatic and germinal cells which may  be
ue to the synergistic effect of different compounds and phyto-
hemicals present in septilin. [60] reported the synergies in the
nhibition of cancer cell proliferation by tea catechin.
As already described septilin is a combination drug, contain-
ng some medicinal plant extracts along with powdered shankha
hasma and Blasmodendron mukul.  The positive responses obtained
n the present study, may  be due to the synergic effects of these
arious compounds.
Synergy is the combined action of different components of a
edicine, leading to potentiating effects which means the effect
f combination is greater than the sum of individual effects. One
uch example in natural products is the synergy between Cinchona
lkaloids as reviewed by Rasoanaivo et al. [77]. In antimutagenic-
ty/anticlastogenicity studies also several authors proposed thegy Reports 3 (2016) 563–571 569
synergistic effects of individual plants/their constituents in bring-
ing out the protective effects. Cevallos et al. [12] observed the
chemo protective effects of spirulina against CP induced muta-
genicity in mouse test system. The positive response obtained in
this study is hypothesised as due to the synergistic action of wide
spectrum of antioxidants present in the algal extract. In the present
context anticlastogenic effects shown by the septilin may be due
to the synergistic effects of bioactive photochemical components
present in the plants.
In conclusion, our study revealed that septilin, a natural drug for-
mulation has a potential to inhibit the clastogenic damage induced
by an anticancer drug, cyclophosphamide. Hence, it could be used
as an adjuvant with toxic chemotherapeutic drugs to enhance their
effectiveness.
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